Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcμR)

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 39, 2012, Pages 15882-15887

  Honjo, Kazuhito ^a   Kubagawa, Yoshiki ^a   Jones, Dewitt M ^a   Dizon, Brian ^b   Zhu, Zilu ^c   Ohno, Hiroshi ^d   Izui, Shozo ^e   Kearney, John F ^b   Kubagawa, Hiromi ^a  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d RIKEN Center for Integrative Medical Sciences   (Japan)

^e UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Autoimmunity; B cell subset; B cell tolerance; Natural antibody

Indexed keywords

AUTOANTIBODY; FC RECEPTOR; IMMUNOGLOBULIN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN M ANTIBODY; IMMUNOGLOBULIN MU CHAIN; NITROPHENYL COUPLED CHICKEN GAMMA GLOBULIN; PHOSPHORYLCHOLINE; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; HAPTEN CARRIER COMPLEX; HOMEOSTASIS; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; T LYMPHOCYTE; WILD TYPE;

ANIMALS; ANTIBODY FORMATION; CELL DIFFERENTIATION; HOMEOSTASIS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MICE; MICE, KNOCKOUT; PLASMA CELLS; RECEPTORS, FC; T-LYMPHOCYTES;

MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84866849886     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1206567109     Document Type: Article

References (43)

1. Cooper MD (2002) Exploring lymphocyte differentiation pathways. Immunol Rev 185: 175-185.
2. Boes M, et al. (1998) Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J Immunol 160:4776-4787. (Pubitemid 28215311)
3. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS (1998) Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 95:10089-10093. (Pubitemid 28415299)
4. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J (1998) A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 188:2381-2386. (Pubitemid 29028511)
5. Baumgarth N, et al. (2000) B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 192:271-280. (Pubitemid 30470309)
6. Subramaniam KS, et al. (2010) The absence of serum IgM enhances the susceptibility of mice to pulmonary challenge with Cryptococcus neoformans. J Immunol 184:5755-5767.
7. Boes M, et al. (2000) Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc Natl Acad Sci USA 97:1184-1189. (Pubitemid 30080833)
8. Ehrenstein MR, Cook HT, Neuberger MS (2000) Deficiency in serum immunoglobulin (Ig)M predisposes to development of IgG autoantibodies. J Exp Med 191:1253-1258.
9. Ehrenstein MR, Notley CA (2010) The importance of natural IgM: Scavenger, protector and regulator. Nat Rev Immunol 10:778-786.
10. Kaveri SV, Silverman GJ, Bayry J (2012) Natural IgM in immune equilibrium and harnessing their therapeutic potential. J Immunol 188:939-945.
11. Ravetch JV, Nimmerjahn F (2008) Fundamental Immunology, ed Paul WE (Lippincott Williams & Wilkins, Philadelphia, PA), pp 684-705.
12. Kubagawa H, et al. (2009) Identity of the elusive IgM Fc receptor (FcmuR) in humans. J Exp Med 206:2779-2793.
13. Vivier E, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331:44-49.
14. Shima H, et al. (2010) Identification of TOSO/FAIM3 as an Fc receptor for IgM. Int Immunol 22:149-156.
15. + phenotype controls T cell-dependent inflammatory responses. Immunity 28:639-650.
16. Chroneos ZC, Baynes JW, Thorpe SR (1995) Identification of liver endothelial cells as the primary site of IgM catabolism in the rat. Arch Biochem Biophys 319:63-73.
17. Briles DE, et al. (2000) Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 68:796-800. (Pubitemid 30056538)
18. Shimada S, et al. (1999) Generation of polymeric immunoglobulin receptor-deficient mouse with marked reduction of secretory IgA. J Immunol 163:5367-5373.
19. Honda S, et al. (2009) Enhanced humoral immune responses against T-independent antigens in Fc μ/muR-deficient mice. Proc Natl Acad Sci USA 106:11230-11235.
20. Li FJ, et al. (2011) Enhanced levels of both the membrane-bound and soluble forms of IgM Fc receptor (FcμR) in patients with chronic lymphocytic leukemia. Blood 118:4902-4909.
21. Vire B, David A, Wiestner A (2011) TOSO, the Fcmicro receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation. J Immunol 187:4040-4050.
22. Hashimoto K, Handa H, Umehara K, Sasaki S (1978) Germfree mice reared on an "antigen-free" diet. Lab Anim Sci 28:38-45. (Pubitemid 8296243)
23. Haury M, et al. (1997) The repertoire of serum IgM in normal mice is largely independent of external antigenic contact. Eur J Immunol 27:1557-1563. (Pubitemid 27254850)
24. Baumgarth N, Tung JW, Herzenberg LA (2005) Inherent specificities in natural antibodies: A key to immune defense against pathogen invasion. Springer Semin Immunopathol 26:347-362. (Pubitemid 40468889)
25. Xiang Z, et al. (2007) FcgammaRIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 8:419-429. (Pubitemid 46745417)
26. Mosser JL, Tomasz A (1970) Choline-containing teichoic acid as a structural component of pneumococcal cell wall and its role in sensitivity to lysis by an autolytic enzyme. J Biol Chem 245:287-298.
27. Fischer W, Behr T, Hartmann R, Peter-Katalinić J, Egge H (1993) Teichoic acid and lipoteichoic acid of Streptococcus pneumoniae possess identical chain structures. A reinvestigation of teichoid acid (C polysaccharide). Eur J Biochem 215:851-857. (Pubitemid 23246861)
28. Snapper CM (2012) Mechanisms underlying in vivo polysaccharide-specific immunoglobulin responses to intact extracellular bacteria. Ann N Y Acad Sci 1253: 92-101.
29. Balázs M, Martin F, Zhou T, Kearney J (2002) Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses. Immunity 17: 341-352. (Pubitemid 35279554)
30. Briles DE, et al. (1981) Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae. J Exp Med 153:694-705. (Pubitemid 11155803)
31. Briles DE, et al. (1987) Naturally occurring antibodies to phosphocholine as a potential index of antibody responsiveness to polysaccharides. J Infect Dis 155:1307-1314. (Pubitemid 17080510)
32. von Bülow GU, van Deursen JM, Bram RJ (2001) Regulation of the T-independent humoral response by TACI. Immunity 14:573-582.
33. Yan M, et al. (2001) Activation and accumulation of B cells in TACI-deficient mice. Nat Immunol 2:638-643. (Pubitemid 32677632)
34. He B, et al. (2010) The transmembrane activator TACI triggers immunoglobulin class switching by activating B cells through the adaptor MyD88. Nat Immunol 11:836-845.
35. Hosokawa T (1979) Studies on B-cell memory. II. T-cell independent antigen can induce B-cell memory. Immunology 38:291-299.
36. Brodeur PH, Wortis HH (1980) Regulation of thymus-independent responses: Unresponsiveness to a second challenge of TNP-Ficoll is mediated by hapten-specific antibodies. J Immunol 125:1499-1505. (Pubitemid 10018553)
37. Obukhanych TV, Nussenzweig MC (2006) T-independent type II immune responses generate memory B cells. J Exp Med 203:305-310. (Pubitemid 43290839)
38. Sato S, Steeber DA, Tedder TF (1995) The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc Natl Acad Sci USA 92:11558-11562.
39. Tsitsikov EN, Gutierrez-Ramos JC, Geha RS (1997) Impaired CD19 expression and signaling, enhanced antibody response to type II T independent antigen and reduction of B-1 cells in CD81-deficient mice. Proc Natl Acad Sci USA 94:10844-10849. (Pubitemid 27430823)
40. Chattopadhyay G, Chen Q, Colino J, Lees A, Snapper CM (2009) Intact bacteria inhibit the induction of humoral immune responses to bacterial-derived and heterologous soluble T cell-dependent antigens. J Immunol 182:2011-2019.
41. Pasare C, Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438:364-368. (Pubitemid 41643953)
42. Gavin AL, et al. (2006) Adjuvant-enhanced antibody responses in the absence of toll-like receptor signaling. Science 314:1936-1938. (Pubitemid 46026117)
43. Booth J, Wilson H, Jimbo S, Mutwiri G (2011) Modulation of B cell responses by Toll-like receptors. Cell Tissue Res 343:131- 140.